Systematic research of H2dedpa derivatives as potent inhibitors of New Delhi Metallo-beta-lactamase-1
Systematic research of H2dedpa derivatives as potent inhibitors of New Delhi Metallo-beta-lactamase-1
复制标题
H2dedpa 衍生物作为新德里 Metallo-β-lactamase-1 有效抑制剂的系统研究
DOI:
10.1016/j.bioorg.2020.103965
复制
发表时间:
2020
影响因子:
5.1
通讯作者:
Zhang En
中科院分区:
文献类型:
--
作者:
Cui De-Yun;Yang Yi;Bai Meng-Meng;Han Jiang-Xue;Wang Cong-Cong;Kong Hong-Tao;Shen Bo-Yuan;Yan Da-Chao;Xiao Chun-Ling;Liu Yi-Shuang;Zhang En
New Delhi Metallo-β-lactamase-1 (NDM-1), a Zn (II)-dependent enzyme, can catalyze the hydrolysis of almost all β-lactam antibiotics including carbapenems, resulting in bacterial antibiotic resistance, which threatens public health globally. Based on our finding that H2dedpa is as an efficient NDM-1 inhibitor, a series of H2dedpa derivatives was systematically prepared. These compounds exhibited significant activity against NDM-1, with IC50values 0.06–0.94 μM.In vitro, compounds6kand6ncould restore the activity of meropenem againstKlebsiella pneumoniae,Escherichia coliandProteus mirabilispossessing either NDM or IMP. In particular, the activity of meropenem againstE. coliproducing NDM-4 could be improved up to 5333 times when these two compounds were used. Time–kill cell-based assays showed that 99.9% ofP. mirabiliswere killed when treated with meropenem in combination with compound6kor6n. Furthermore, compounds6kand6nwere nonhemolytic (HC50> 1280 μg/mL) and showed low toxicity toward mammalian (HeLa) cells. Mechanistic studies indicated that compounds6kand6ninhibit NDM-1 by chelating the Zn2+ion of the enzyme.